Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariela Cabrera

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
BMC Pregnancy and Childbirth|October 7, 2023
Missed opportunities in aspirin prescribing for preeclampsia preventionNoreen Singh, Saskia Shuman, Jacqueline Chiofalo, et al.
American Journal of Perinatology|April 24, 2024
Use of Respiratory and Contact Precautions to Decrease the Spread of SARS-CoV-2 Infection Was Not Associated with a Decrease in Endometritis-Intra-Amniotic InfectionJacqueline Roig, Chelsea A DeBolt, Mariela Cabrera, et al.
Acta Neuropathologica Communications|December 20, 2018
Analysis of spinal and muscle pathology in transgenic mice overexpressing wild-type and ALS-linked mutant MATR3Christina Moloney, Sruti Rayaprolu, John Howard, et al.
The Journal of Comparative Neurology|February 16, 2016
Heterogeneity of Matrin 3 in the developing and aging murine central nervous systemSruti Rayaprolu, Simon D'Alton, Keith Crosby, et al.
Acta Neuropathologica Communications|November 20, 2016
Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotypeChristina Moloney, Sruti Rayaprolu, John Howard, et al.
Acta Neuropathologica Communications|December 15, 2017
Retraction Note: Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotypeChristina Moloney, Sruti Rayaprolu, John Howard, et al.
Medicina|June 28, 2023
Serological response to SARS-CoV-2 vaccines in patients with multiple sclerosis in ArgentinaJuan I Rojas, Ricardo Alonso, Mariela Cabrera, et al.
Multiple Sclerosis and Related Disorders|September 26, 2025
Progression independent of relapse activity (PIRA) in the Era of high-efficacy treatmentsRicardo Alonso, Magdalena Casas, Juan Ignacio Rojas, et al.
Multiple Sclerosis and Related Disorders|June 8, 2019
Access and unmet needs to multiple sclerosis care in a cohort of Argentinean patientsEdgar Carnero Contentti, Juan Pablo Pettinicchi, Pablo A López, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 27, 2023
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodiesRicardo Alonso, Magdalena Casas, Luciana Lazaro, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
BMC Pregnancy and Childbirth|October 7, 2023
Missed opportunities in aspirin prescribing for preeclampsia preventionNoreen Singh, Saskia Shuman, Jacqueline Chiofalo, et al.
American Journal of Perinatology|April 24, 2024
Use of Respiratory and Contact Precautions to Decrease the Spread of SARS-CoV-2 Infection Was Not Associated with a Decrease in Endometritis-Intra-Amniotic InfectionJacqueline Roig, Chelsea A DeBolt, Mariela Cabrera, et al.
Acta Neuropathologica Communications|December 20, 2018
Analysis of spinal and muscle pathology in transgenic mice overexpressing wild-type and ALS-linked mutant MATR3Christina Moloney, Sruti Rayaprolu, John Howard, et al.
The Journal of Comparative Neurology|February 16, 2016
Heterogeneity of Matrin 3 in the developing and aging murine central nervous systemSruti Rayaprolu, Simon D'Alton, Keith Crosby, et al.
Acta Neuropathologica Communications|November 20, 2016
Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotypeChristina Moloney, Sruti Rayaprolu, John Howard, et al.
Acta Neuropathologica Communications|December 15, 2017
Retraction Note: Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotypeChristina Moloney, Sruti Rayaprolu, John Howard, et al.
Medicina|June 28, 2023
Serological response to SARS-CoV-2 vaccines in patients with multiple sclerosis in ArgentinaJuan I Rojas, Ricardo Alonso, Mariela Cabrera, et al.
Multiple Sclerosis and Related Disorders|September 26, 2025
Progression independent of relapse activity (PIRA) in the Era of high-efficacy treatmentsRicardo Alonso, Magdalena Casas, Juan Ignacio Rojas, et al.
Multiple Sclerosis and Related Disorders|June 8, 2019
Access and unmet needs to multiple sclerosis care in a cohort of Argentinean patientsEdgar Carnero Contentti, Juan Pablo Pettinicchi, Pablo A López, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 27, 2023
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodiesRicardo Alonso, Magdalena Casas, Luciana Lazaro, et al.
Pageof 2